First Patient Dosed in LUMINOS-101 LEARN MORE
Reshaping the Standard of Care for the Treatment of Cancer
Istari Oncology is a clinical-stage biotechnology company focused on developing and commercializing groundbreaking immuno-oncology therapies with the potential to improve the standard of care for a wide range of solid tumors, including glioblastoma and melanoma.
TECHNOLOGIES IN CLINICAL DEVELOPMENT
Polio Virus Sabin-Rhinovirus Poliovirus (PVSRIPO)
Antibody Toxin Conjugates (ATCs)
OUR SCIENCE
Find out more about our breakthrough PVSRIPO platform
PIPELINE
For more on how our technologies are advancing
NEWS
Access the latest updates and research